Digitalization of society is leading to an increasingly complex interweaving of people and technology. In the pharmaceutical, biotech and life science industries these socio-technical hybrids can be seen in the field of personalized medicine. Here the complex pharmaceutical value chain - from the laboratory to drug application - is advanced using technological innovations and by linking the real and digital world. All while giving careful consideration to patient welfare. Promises are made and promises should be kept.
Technologies such as artificial intelligence, Big Data and algorithmic decision making, through to concrete applications such as cell-gene therapy, have enormous potential. However, in order to harness this potential in a safe, sustainable, fair and value-oriented way, transdisciplinary and cross-sector discourse is needed.
At the ZETA Symposium the elite of the pharmaceutical and biotech industry will meet motivated visionaries, hear about latest industry trends, discuss technical approaches to tackle the problems of the future and learn from scientific solutions. Together we will discuss the pressing questions:
How can we sustainably ensure patient safety in a globalized digital world?
How can we improve our performance all the way from lab to smart manufacturing?
